Related Experiment Video
Updated: May 27, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering
Published on: October 12, 2012
Abnormal granulation of blood granulocytes in mucopolysaccharidosis VI-a case report
Chaitra Krishnagiri1, Raghupathi R Ajanahalli, Suma Kashyap
1Bangalore Medical College and Research Institute, Bangalore, Karnataka, India. chaitra.krishnagiri@gmail.com
Abstract:
Mucopolysaccharidosis (MPS) is a group of lysosomal storage disorders in which there is deficiency of specific enzymes. Depending upon the enzyme which is deficient and the nature of the material that accumulates at various tissues, the MPS is divided into 8 types (MPS I to MPS VIII). In MPS VI, deficiency of aryl B sulfatase leads to the accumulation of dermatan sulfate. Mucopolysaccharidosis VI, also called as Maroteaux-Lamy syndrome, in its severe form presents with bony lesions, corneal clouding, hepatosplenomegaly, cardiovascular abnormalities, and central nervous system deterioration. This form of MPS features the most striking abnormal granulation in the circulating white blood cells. Mucopolysaccharidosis VI has an estimated global incidence of 1 in 340,000. The number of cases showing abnormal granules in the cytoplasm of leucocytes is still rarer. We report a case of MPS VI with abnormal granules in the circulating blood leukocytes.
Insights
Mucopolysaccharidosis VI (MPS VI), a rare lysosomal storage disorder, involves dermatan sulfate accumulation due to aryl B sulfatase deficiency. This case highlights MPS VI presenting with rare abnormal granules in circulating leukocytes.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Mucopolysaccharidosis (MPS) encompasses a group of inherited lysosomal storage disorders.
- These disorders result from deficiencies in specific lysosomal enzymes, leading to the accumulation of glycosaminoglycans.
- MPS is classified into eight types (MPS I-VIII) based on the deficient enzyme and accumulating substrate.
Observation:
- Mucopolysaccharidosis VI (MPS VI), also known as Maroteaux-Lamy syndrome, is caused by a deficiency in the enzyme aryl B sulfatase.
- This deficiency leads to the accumulation of dermatan sulfate.
- Severe MPS VI manifestations include skeletal deformities, corneal clouding, enlarged liver and spleen, cardiac issues, and neurological decline.
Findings:
- MPS VI is characterized by distinctive abnormal granulation in circulating white blood cells.
- The global incidence of MPS VI is approximately 1 in 340,000 births.
- Cases with abnormal leukocyte cytoplasmic granules are exceptionally rare.
Implications:
- This case report documents a rare presentation of MPS VI with abnormal leukocyte granules.
- Understanding these rare presentations aids in early diagnosis and management of MPS VI.
- Further research into the pathobiology of leukocyte abnormalities in MPS VI may reveal novel diagnostic markers.
Related Concept Videos
Proteoglycans
Lysosomal Hydrolases